Skip to main content
Caplight Logo









serb

serb

Private

Last Round

Debt

Jul 15, 2025

Est. Valuation

$756M

Total Funding Raised

$0

Company Overview

A specialty pharmaceutical group focused on prescription medicines for rare and life-threatening diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

serb Comparables

Compare serb with similar companies based on industry and business-model similarity.

No public comparables are available for serb. Request access to learn about comparables coverage.

Request access

serb Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 15, 2025
Private EquityJun 8, 2023
Private EquityFeb 28, 2021
Buyout/LBOJun 9, 2017

serb Filings

Explore SEC and related filing metadata, where available.

serb filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

Headquarters—
Year Founded1951
Last FundingJul 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?